Gainers & Losers
Tue Feb 10 2026 09:55:56- Eternal share price
- ₹303.805.18%
- Tata Steel share price
- ₹207.802.82%
- Mahindra & Mahindra Ltd share price
- ₹3,675.201.79%
- Tech Mahindra share price
- ₹1,645.401.51%
- Larsen & Toubro Ltd share price
- ₹4,169.701.37%
Active Stocks
Tue Feb 10 2026 10:25:01- Tata Steel share price
- ₹207.952.89%
- Yes Bank share price
- ₹21.40-0.79%
- Suzlon Energy share price
- ₹47.72-1.00%
- Eternal share price
- ₹303.855.19%
- Gail (India) share price
- ₹164.600.58%
Business News/Market/Market Stats/Nectar Lifesciences share price/ Nectar Lifesciences Profit Loss Annual
Nectar Lifesciences Profit & Loss Annual
13.75 +0.14 (1.03%)Updated : 10 Feb 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 1,758.83 | 1,591.73 | 1,528.87 | 1,567.26 |
| Other Net | 11.40 | 2.97 | 3.34 | -8.84 |
| Diluted Weighted Average Shares | 22.43 | 22.43 | 22.43 | 22.43 |
| Gain( Loss)on Saleof Assets | -0.01 | 0.00 | 40.41 | 9.41 |
| Depreciation/ Amortization | 62.39 | 60.72 | 59.12 | 56.97 |
| Operating Income | -88.86 | 92.36 | -5.20 | 101.57 |
| Net Income | -113.68 | 5.00 | -24.18 | 25.05 |
| Income Availableto Com Excl Extra Ord | -113.68 | 5.00 | -24.18 | 25.05 |
| Other Operating Expenses Total | -3.08 | -1.52 | -0.91 | - |
| Net Income Before Taxes | -161.53 | 18.27 | -42.42 | 34.08 |
| Net Income After Taxes | -113.68 | 5.00 | -24.18 | 25.05 |
| Income Availableto Com Incl Extra Ord | -113.68 | 5.00 | -24.18 | 25.05 |
| Costof Revenue Total | 1,509.22 | 1,368.16 | 1,317.40 | 1,369.50 |
| Gross Profit | 160.76 | 315.93 | 206.27 | 299.33 |
| Interest Inc( Exp) Net- Non- Op Total | -84.06 | -77.05 | -80.97 | -68.06 |
| Unusual Expense( Income) | 0.00 | - | 0.00 | 0.00 |
| Diluted Net Income | -113.68 | 5.00 | -24.18 | 25.05 |
| Provisionfor Income Taxes | -47.85 | 13.27 | -18.24 | 9.03 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | -113.68 | 5.00 | -24.18 | 25.05 |
| Total Revenue | 1,669.97 | 1,684.09 | 1,523.67 | 1,668.83 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 1,669.97 | 1,684.09 | 1,523.67 | 1,668.83 |
| Selling/ General/ Admin Expenses Total | 190.30 | 164.38 | 153.26 | 140.79 |
| Diluted Normalized EPS | -5.07 | 0.22 | -2.25 | 0.81 |
| Diluted EPS Excluding Extra Ord Items | -5.07 | 0.22 | -1.08 | 1.12 |
| Total Adjustmentsto Net Income | - | - | - | 0.01 |
*All figures in crores except per share values
Nectar Lifesciences Quick Links
Nectar Lifesciences Dividend Nectar Lifesciences Bonus Nectar Lifesciences News Nectar Lifesciences AGM Nectar Lifesciences Rights Nectar Lifesciences Splits Nectar Lifesciences Board Meetings Nectar Lifesciences Key Metrics Nectar Lifesciences Shareholdings Nectar Lifesciences Balance Sheet Nectar Lifesciences Cashflow Nectar Lifesciences Q1 Results Nectar Lifesciences Q2 Results Nectar Lifesciences Q3 Results Nectar Lifesciences Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
305.75+16.90(5.85%)
207.50+5.40(2.67%)
367.50+5.65(1.56%)
1,577.70-24.35 (-1.52%)
968.35-14.65 (-1.49%)